Saryah Azmat - Jul 20, 2023 Form 3 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
Chief Business Officer
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Jul 20, 2023
Transactions value $
$0
Form type
3
Date filed
7/20/2023, 09:47 PM
Next filing
Oct 17, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 124K $9.34 Direct F1
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 52.8K $10.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award vested on November 1, 2020, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F2 One fourth (1/4th) of the shares subject to the option award vested on January 20, 2023, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney